Hepatitis Single Topic Conference 

|

Hepatitis Single Topic Conference 
Co-sponsored by the CDC
Chronic Viral Hepatitis – Strategies to Improve Effectiveness of Screening and Treatment
Emory Conference Center, Atlanta, GA
June 4-5, 2011

Course Directors:
John W. Ward, MD; Anna S.F. Lok, MD; David L. Thomas, MD; and Hashem B. El-Serag, MD, MPH

This conference will cover the differences between efficacy and effectiveness of approaches to viral hepatitis screening, care referral and clinical management of chronic hepatitis B virus (HBV), and chronic hepatitis C virus (HCV) infections.

Goals and Objectives:

• Understand the epidemiology of chronic hepatitis B and C
  
  
• Understand the differences between efficacy and effectiveness of approaches to viral hepatitis screening, care referral, and clinical management
  
  
• Understand the role of community engagement and education in viral hepatitis prevention and care
  
  
• Understand the screening and care referral strategies to identify persons with chronic viral hepatitis and mechanisms to refer them to care
  
  
• Understand the models of care that optimize patient acceptance and adherence to therapy
  
  
• Understand the options for clinical monitoring and therapy

Target Audience:
Hepatologists, Gastroenterologists, Primary Care Clinicians, Health Care Managers, Insurers, Public Health Professionals, Policymakers, Industry Representatives and Patient Advocate Organizations 

*Continuing Medical Education credits will not be provided for this conference.

This program is supported by the AASLD/Roche Pharmaceuticals Hepatitis Single Topic Conference Endowment and is co-sponsored by the Centers for Disease Control and Prevention (CDC). Additional program support is provided by educational grants from Gilead.